The Neurology Of Angels

The Neurology Of Angels

by Krista Tibbs
5.0 3

Paperback

$12.99
View All Available Formats & Editions
Eligible for FREE SHIPPING
  • Get it by Thursday, August 24 ,  Order by 12:00 PM Eastern and choose Expedited Delivery during checkout.

Overview

The Neurology Of Angels by Krista Tibbs

The Neurology of Angels is a novel about the hearts inside the business and politics of drug development and the consequences of a choice between saving one child and treating thousands.

Galen is a neuroscientist and entrepreneur who loses everything to develop a cure for stroke. Eddy is a devoted father who enters politics on a mission to lower the cost of prescription drugs. Elizabeth is a pharmaceutical industry lawyer who is raising a daughter with a rare and fatal genetic illness.

Their families become forever entwined as the three parents engage in a tug-of-war over a failing system of good intentions. In the wake, heroes are born.

Product Details

ISBN-13: 9780981880303
Publisher: Friction Publishing
Publication date: 08/10/2008
Pages: 284
Product dimensions: 6.00(w) x 9.00(h) x 0.64(d)

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews

The Neurology Of Angels 5 out of 5 based on 0 ratings. 3 reviews.
Anonymous More than 1 year ago
Anonymous More than 1 year ago
Guest More than 1 year ago
The Neurology of Angels is a powerful novel exploring health care issues through the intertwined lives of several people for whom drug availability is a daily personal dilemma. Two parents whose children suffer from rare and fatal illnesses ¿ one with an existing but expensive cure ¿ one with no cure at all ¿ play tug-of-war over laws and regulations and resources, while a scientist-turned-entrepreneur faces heart-rending choices about how and when his miracle drug will be used ¿ and who will receive it. This is a powerful novel about important contemporary issues. How do factors like Medicare, generic drugs, and international sales impact the availability of drugs for the populace? The complex interaction of FDA mandates, legislation, and investment opportunities essentially control who in this country has access to the newest drugs ¿ and who does not. The FDA¿s concern is with scientific proof of effectiveness and safety, and the pleas of individuals who might die waiting for that proof go unheard. Legislators make decisions based on human reactions to health care problems faced by Americans, without truly understanding the economic fallout of their actions. Investors pour their money into profitable companies, forcing decisions that favor treatments for the common and the many over treatments for the rare and the few. And at the heart of this novel, a handful of people with good intentions unknowingly work at cross-purposes in an attempt to save these two children and thousands like them.